Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

LYSIS SOLUTION - ANVISA Registration 80392960027

Access comprehensive regulatory information for LYSIS SOLUTION in Brazil's medical device market through Pure Global AI's free database. This Risk Class I medical device is registered under ANVISA number 80392960027 and manufactured by VIXTAL REAGENTS AND TECHNOLOGIES LTDA ME. The registration is held by VIXTAL REAGENTS AND TECHNOLOGIES LTDA ME with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including DIAGNO SOLUÇÕES EM DIAGNÓSTICO LTDA, SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Competitors
5 Recent Registrations
80392960027
Registration Details
ANVISA Registration Number: 80392960027
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Device Details

VIX LYSE DIFF MD
Risk Class I

Registration Details

80392960027

25351499248202361

07448726000130

Company Information

Brazil
PT: BRASIL

Dates and Status

Sep 04, 2023

VIGENTE

09/18/2025 19:00:01